ARM’s hybrid 2024 Cell & Gene State of the Industry Briefing attracted over 800+ key stakeholders in the field. This event included ARM’s annual yearly update on the sector’s progress followed by two noteworthy sessions featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in the coming year.

The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the entire cell and gene therapy community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.